Ruptured abdominal aortic aneurysm: lower mortality with endovascular treatment at an experienced center.

Original title: Mortality from ruptured abdominal aortic aneurysms: clinical lessons from a comparison of outcomes in England and the USA. Reference: Karthikesalingam A et al. Lancet. 2014;383:963-969.

Treatment strategy for rAAA patients may vary according to the different centers. This study analyzed in-hospital mortality, and mortality after intervention of all patients admitted with rAAA between 2005 and 2010 in USA (n=23838) and compared outcomes with a similar population in England (n=11799). 

Global in-hospital mortality was lower in the USA than in England (53.05% vs. 65.9%; p<0.0001); however, looking into patients that received some kind of intervention, mortality was similar (41.7% vs 41.6%).

Interventions (conventional surgical or endovascular repair) were more frequent in USA than in England (80.4% vs 58.4%; p<0.001), as frequent were specifically endovascular interventions (20.8% vs 8.5%, p<0.0001). These differences persisted after aged matched and sex matched comparisons.

In both countries, mortality decreased with endovascular treatment. Center experience in endovascular repair and weekday admission were also predictors of lower mortality.

Conclusion

In-hospital survival and intervention rates (especially endovascular) are lower in England than in USA for patients admitted with rAAA. Patients that received endovascular treatment saw lower mortality rates.

Editorial Comment

The absence of follow up beyond hospital discharge is a limitation to this study, as it is the lack of data on anatomical characteristics or clinical status in deciding between conventional surgical strategy vs. endovascular repair with prosthesis.

As in most cases, prevention with a relatively simple screening to allow programmed treatment would greatly reduce mortality for AAA and save the efforts it requires once ruptured. In the event of rupture, the best strategy to reduce mortality seems to be endovascular treatment in an experienced center.

SOLACI.ORG

More articles by this author

AHA/ACC Guideline on the Management of Acute Pulmonary Embolism 2026

The 2026 ACC/AHA guideline for the management of acute pulmonary embolism (PE) introduces a conceptual shift by replacing the traditional “risk-based” classification with an...

FFR Assessment for the Selection of Hypertensive Patients Who Benefit from Renal Stenting

Atherosclerotic renal artery stenosis (ARAS) represents one of the main causes of secondary hypertension (HTN) and is associated with a higher risk of renal...

Transcatheter Deep Vein Arterialization in Critical Limb Ischemia Without Revascularization Options

Chronic limb-threatening ischemia in patients without conventional revascularization options represents one of the most challenging scenarios within peripheral arterial disease, with 1-year major amputation...

Duration of Smoking Cessation and Risk of Amputation After Revascularization in Critical Limb Ischemia

Critical limb ischemia (CLI) is associated with high rates of amputation and mortality. Although smoking cessation improves outcomes after revascularization, the impact of the...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

CRT 2026 | TAVI-CLOSE Trial: Dual Suture vs Suture + Plug for Vascular Closure After Transfemoral TAVI

The transfemoral approach is the predominant strategy for transcatheter aortic valve implantation (TAVI). Although vascular complications are currently less frequent, they remain relevant determinants...

CRT 2026 | NAVITOR IDE: Hemodynamic Outcomes and 5-Year Durability of an Intra-Annular Self-Expanding Transcatheter Aortic Valve

As TAVI expands into younger populations and patients with lower surgical risk, prosthesis durability has become a key aspect of long-term management. The NAVITOR...

CRT 2026 | CUT-DRESS Trial: Lesion Preparation with Cutting Balloon

In-stent restenosis (ISR) continues to represent a relevant clinical challenge in contemporary coronary angioplasty practice. Despite advances in drug-eluting stents, neointimal hyperplasia and suboptimal...